Michael Cope
Angel Investor
Dallas, United States
Michael Cope is a seed investor in Dallas focused on Health Care and Apps. Michael Cope - Founder, CEO @ Cope Ventures
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Michael Cope invests in
Stages Michael Cope invests in
Countries Michael Cope invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Apps 1 (25%)
- mHealth 1 (25%)
- Wearables 1 (25%)
- Medical Device 1 (25%)
Stage
- Seed 1 (25%)
- Angel 1 (25%)
- Pre-Seed 1 (25%)
- Series A 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Insight Optics, is an impact driven startup dedicated to connecting Primary Care Providers with local specialists for assisted diagnostics. We do the heavy lifting with machine learning and computer vision to ensure untrained individuals have captured the right content and that it is of a diagnosable quality prior to transmission. We have built oursolution to ensure that we can capture non-adherent patients where they already are by deskilling the process and improving accessibility for the most rural, impoverished, and marginalized populations.Business Overview: Insight Optics empowers primary care providers (PCPs) to record and refer preventative pre-screening videos to local specialists for assisted diagnostics. Our goal is to enable PCPs to efficiently detect early signs of preventable diseases before permanent damage is done. We accomplish this by providing PCPs a platform to connect and send patient data to local specialists. This allows both users to monetize otherwise unrealized referral incentives and provide better care.Problem: Over 154 million patients in the United States are recommended for an annual retinal exam, especially those with a history of diabetes or high blood pressure. Unfortunately, less than 50% of this population will receive their screening due to the difficulty of visiting a specialist, lack of education or available specialists. However, most of these patients do see PCPs annually. Solution: We’ve developed a telemedicine PaaS, enabling PCPs to record and refer retinal exams to local specialists for assisted review. PCPs create a new revenue stream through reimbursements and government incentives. Specialists find qualified leads and increase their screening capacity without the need for in-person appointments in a non-adherent population.Benefits: The OptoView system acts as a new revenue stream for both PCPs and specialists through reimbursement. The tool satisfies HEDIS requirements for PCPs and acts as a lead generation tool for specialists to find new patients. Annual reports determine whether managed care organizations receive reimbursements or penalties from state and federal agencies. Our application is designed to satisfy the requirements for annual diabetic eye screenings, increasing an organization’s compliance rates and ophthalmologists prioritize sick patients. | $190K / Pre-Seed / Nov 10, 2016 | ||
| Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina. | $5M / Series A / Aug 12, 2014 | ||
| Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina. | $760K / Seed / Aug 15, 2013 | ||
| See all 4 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Michael Cope invest in?
Michael Cope invests primarily in Health Care, Apps and mHealth startups, most often at Seed and Angel stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Michael Cope?
Public channels for Michael Cope include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michael Cope last invest?
The most recent investment recorded for Michael Cope closed in Nov 2016. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
